Phase 2 Breast Cancer Trial, Recruiting (NCT05020574)

Phase 2 Breast Cancer Trial, Recruiting NCT05020574 Sponsor: University of California, San Francisco Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05020574 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with breast cancer (confirmed by a tissue test) or carry a genetic risk factor for breast cancer
You are 18 years of age or older
You are planning to have a mastectomy with immediate placement of a tissue expander or breast implant at the same time
You are able to understand and are willing to sign a written consent form
It has been at least 4 weeks since you finished chemotherapy or radiation therapy

Who may not be able to join:

You have a serious medical condition or abnormal lab results that could put you at risk by participating (confirm with trial site)
You are currently pregnant or breastfeeding
You have taken antibiotics at any point in the 90 days before signing the consent form
You have taken probiotic supplements or products at any point in the 90 days before signing the consent form
You have a known or reported allergic reaction to the specific antibiotics used in this study (confirm with trial site for details on which antibiotics are involved)
You are male

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05020574

Sponsor: University of California, San Francisco

Phase: Phase 2

Status: Recruiting

Condition: Breast Cancer

More information: https://clinicaltrials.gov/study/NCT05020574

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with breast cancer (confirmed by a tissue test) or carry a genetic risk factor for breast cancer
You are 18 years of age or older
You are planning to have a mastectomy with immediate placement of a tissue expander or breast implant at the same time
You are able to understand and are willing to sign a written consent form
It has been at least 4 weeks since you finished chemotherapy or radiation therapy

Who may not be able to join:

You have a serious medical condition or abnormal lab results that could put you at risk by participating (confirm with trial site)
You are currently pregnant or breastfeeding
You have taken antibiotics at any point in the 90 days before signing the consent form
You have taken probiotic supplements or products at any point in the 90 days before signing the consent form
You have a known or reported allergic reaction to the specific antibiotics used in this study (confirm with trial site for details on which antibiotics are involved)
You are male

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

University of California, San Francisco

Registry

ClinicalTrials.gov

Start date

28 September 2021

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of tissue samples obtained successfully over time; Proportion of aspirate samples obtained successfully overall; Proportion of tissue samples successfully producing microbiome data; Proportion of aspirate samples successfully producing microbiome data; Proportion of any samples successfully producing microbiome data; Correlation of the change in breast microbiome over time with total duration of antibiotics (Cohort A only)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov